Client News

DEBRA Research Invests in Topadur to Advance Small-Molecule Therapies for Dystrophic Epidermolysis Bullosa

CorTec Brain Interface Electrodes Record Stable Signals for More Than Four Years

Formycon and Biocelys Combine Complementary Development and Manufacturing Expertise in New Biosimilar Project FYB286

invIOs publishes positive clinical data on CBL-B-silenced autologous cell therapy APN401 in peer-reviewed journal

BIOTECH SUMMIT AUSTRIA Highlights Growing Momentum Across Austria’s Biotech Sector

seragy Launches with €12 Million Financing to Advance Quantitative Biomarkers for Neurodegenerative Diseases

AL-S Pharma Appoints Harry Welten as Chief Executive Officer

NVision Deploys POLARIS at UCLouvain to Advance Cancer Metabolism Research

PL BioScience Launches PL Synergy to Simplify and Standardize MSC Research

Formycon and Zydus: FYB206 Becomes First Publicly Announced Keytruda® Biosimilar Accepted for Review by FDA